|
US6607727B1
(en)
|
1991-08-26 |
2003-08-19 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
|
|
US6235288B1
(en)
|
1992-08-26 |
2001-05-22 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
|
|
CN1118573A
(zh)
*
|
1993-02-26 |
1996-03-13 |
斯克瑞普斯研究所 |
诱导细胞毒t淋巴细胞应答乙型肝炎病毒的肽类
|
|
US5688506A
(en)
|
1994-01-27 |
1997-11-18 |
Aphton Corp. |
Immunogens against gonadotropin releasing hormone
|
|
WO1995026365A1
(en)
*
|
1994-03-28 |
1995-10-05 |
United Biomedical, Inc. |
Synthetic peptide based immunogens for the treatment of allergy
|
|
US6410022B1
(en)
|
1995-05-01 |
2002-06-25 |
Avant Immunotherapeutics, Inc. |
Modulation of cholesteryl ester transfer protein (CETP) activity
|
|
JP3910635B2
(ja)
|
1995-06-06 |
2007-04-25 |
アバント イミュノーセラピューティクス,インコーポレイテッド |
Hdlコレステロールレベルを増大する方法
|
|
US5843462A
(en)
|
1995-11-30 |
1998-12-01 |
Regents Of The University Of Minnesota |
Diphtheria toxin epitopes
|
|
TR199801722T2
(xx)
|
1996-03-01 |
1998-12-21 |
Novartis Ag |
Peptit imm�nojenler.
|
|
WO1997040161A1
(en)
*
|
1996-04-19 |
1997-10-30 |
Henry M. Jackson Foundation For The Advancement Of Military Medecine |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
|
|
JP2000510332A
(ja)
|
1996-04-19 |
2000-08-15 |
ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン |
インチミンを単独で、または1以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法
|
|
US6284533B1
(en)
|
1996-05-01 |
2001-09-04 |
Avant Immunotherapeutics, Inc. |
Plasmid-based vaccine for treating atherosclerosis
|
|
US6846808B1
(en)
|
1996-05-01 |
2005-01-25 |
Avant Immunotherapeutics, Inc. |
Plasmid-based vaccine for treating atherosclerosis
|
|
US6309646B1
(en)
|
1996-05-09 |
2001-10-30 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
|
|
DE69739233D1
(de)
*
|
1996-06-25 |
2009-03-12 |
Pepscan Systems Bv |
Ein durch labile bindung an einen träger gebundenes antigen enthaltender impstoff
|
|
EP0996717B1
(en)
*
|
1997-08-05 |
2005-12-07 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Immunoprotective influenza antigen and its use in vaccination
|
|
EP1037663A2
(en)
|
1997-12-16 |
2000-09-27 |
Regents Of The University Of Minnesota |
Methods to treat undesirable immune responses
|
|
US6107021A
(en)
*
|
1998-06-20 |
2000-08-22 |
United Biomedical, Inc. |
Synthetic peptide vaccines for foot-and-mouth disease
|
|
US6025468A
(en)
*
|
1998-06-20 |
2000-02-15 |
United Biomedical, Inc. |
Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
|
|
TWI227241B
(en)
|
1998-06-20 |
2005-02-01 |
United Biomedical Inc |
IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
|
|
US6090388A
(en)
*
|
1998-06-20 |
2000-07-18 |
United Biomedical Inc. |
Peptide composition for prevention and treatment of HIV infection and immune disorders
|
|
WO2000032626A1
(en)
*
|
1998-11-25 |
2000-06-08 |
Regents Of The University Of Minnesota |
Methods of using epitope peptides of human pathogens
|
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
US6783761B2
(en)
|
2000-05-05 |
2004-08-31 |
Aphton Corporation |
Chimeric peptide immunogens
|
|
US6780969B2
(en)
*
|
2000-12-22 |
2004-08-24 |
United Biomedical, Inc. |
Synthetic peptide composition as immunogens for prevention of urinary tract infection
|
|
US6906169B2
(en)
*
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
US8088388B2
(en)
*
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
KR100994748B1
(ko)
*
|
2002-04-19 |
2010-11-17 |
더 가버닝 카운실 오브 더 유니버시티 오브 토론토 |
알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물
|
|
US8709998B2
(en)
|
2003-04-22 |
2014-04-29 |
Ipsen Pharma S.A.S. |
Peptide vectors
|
|
WO2006026834A1
(en)
*
|
2004-09-10 |
2006-03-16 |
The Council Of The Queensland Institute Of Medical Research (Qimr) |
Truncated lhrh formulations
|
|
US7964200B2
(en)
|
2005-05-18 |
2011-06-21 |
Children's Hospital & Research Center At Oakland |
Methods and compositions for immunizing against Chlamydia infection
|
|
EP1890725A2
(en)
*
|
2005-06-01 |
2008-02-27 |
Pfizer Products Inc. |
Vaccine compositions and methods for the treatment of urinary incontinence
|
|
US20100286029A1
(en)
*
|
2007-09-11 |
2010-11-11 |
Dorian Bevec |
Use of a peptide as a therapeutic agent
|
|
JP4535174B2
(ja)
|
2008-07-11 |
2010-09-01 |
トヨタ自動車株式会社 |
車両の制御装置および制御方法
|
|
HUE051277T2
(hu)
|
2012-11-16 |
2021-03-01 |
United Biomedical Inc |
Szintetikus peptiden alapuló sürgõsségi vakcina ragadós száj- és körömfájás (FMD) ellen
|
|
US20170216418A1
(en)
*
|
2014-07-25 |
2017-08-03 |
United Biomedical, Inc. |
Immunogenic lhrh composition and use thereof in pigs
|
|
SG11201908998XA
(en)
*
|
2017-03-30 |
2019-10-30 |
Progastrine Et Cancers S A R L |
Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule
|
|
MX2021007446A
(es)
*
|
2018-12-19 |
2021-09-08 |
United Biomedical Inc |
Epítopos artificiales promiscuos de linfocitos t colaboradores como estimuladores inmunes para inmunógenos peptídicos sintéticos.
|
|
TW202144387A
(zh)
*
|
2020-02-11 |
2021-12-01 |
美商聯合生物醫學公司 |
針對胰島澱粉樣多肽(iapp)的胜肽免疫原及其預防和治療與聚集iapp相關疾病的製劑
|